Is mammographic breast density a risk factor for breast cancer? Radiological point of view;Le sein densemammographique est-il à risque de cancer du sein? Le point de vue du radiologue

Reproduction Humaine et Hormones

Volumn 15, Issue 5, 2002, Pages 335-340

  Tristant, Henri ^a   Chiche, Jean François ^a   Ĺvy, Laurent ^a  

^a Institut de Radiologie   (France)

Author keywords

Breast cancer; Breast density; Mammograpliy; Risk; Screening

Indexed keywords

ADIPOSE TISSUE; AGE; BREAST CANCER; CANCER DIAGNOSIS; CANCER RISK; CANCER SCREENING; CONFERENCE PAPER; CORRELATION ANALYSIS; DENSITY; DISEASE CLASSIFICATION; ECHOMAMMOGRAPHY; FIBROCYSTIC BREAST DISEASE; HORMONAL THERAPY; HORMONE SUBSTITUTION; HUMAN; MAMMARY GLAND; MAMMOGRAPHY; MENOPAUSE; PARENCHYMA; RADIODIAGNOSIS; SENSITIVITY AND SPECIFICITY;

EID: 0036657787     PISSN: 09943919     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (34)

1. Pankow JS, Vachon C M, Kuni CC, King RA, Arnett DK, Grabrick DM, Rich SS, Anderson VE, Sellers TA.: Genetic analysis of mammographic breast density in adult women: evidence of the gene effect. J Natl Cancer Institute 1997; 89: 549-56.
2. WOLFE JN.: Breast patterns as an index of risk for developing breast cancer. Am J Roentgenol 1976; 126: 1130-9.
3. Page D, Winfield A.: The dense mammogram. Am J Roentgenol 1986; 147: 487-9.
4. c éd. (traduction française). SFR, Paris. Société Française de Radiologie. 2001.
5. Lee-Han H, Cooke G, Boyd N.: Quantitative evaluation of mammographic densities: a comparison of methods of assessment. European J Cancer Prevention 1995; 4: 285-92.
6. Tahoces PG, Correa J, Souto M, Gomez L, Vidal JJ.: Computer-assisted diagnosis: the classification of mammographic breast parenchymal patterns. Phys Med Biol 1995; 40: 103-17.
7. c, Journées Nationales de la Société Française de sénologie et de pathologie mammaire. Sauramps Médical. Clermont-Ferrand. 1993; 167-86.
8. Stomper PC, D'souza DJ, Di Nitto PA, Arredonto MA.: Analysis of parenchymal density on mammograms in 1353 women 25-79 years old. Am J Roentgenol 1996; 167: 1261-5.
9. Kopans DB.: Conventional wisdom: observation, experience, anecdote, and science in breast imaging. Am J Roentgenol 1994; 162: 299-303.
10. Tabar L, Dean P.: Mammographic parenchymal patterns. Risk indicator for breast cancers? JAMA 1982; 247: 185-9.
11. White E, Velentgas P, Mandelson MT, Lehman CD, Elmore JG, Porter P, Yasui Y, Taplin SH.: Variation in mammographic breast density by time in menstrual cycle among women aged 40-49 years. J Natl Cancer Inst 1998; 90: 906-10.
12. Spicer D, Ursin G, Parisky Y, Pearce J, Shoupe D, Pike A, Pike M.: Changes in mammographic densities induced by a hormonal contraceptive designed to reduce breast cancer risk. J Natl Cancer Inst 1994; 86: 431-6.
13. Gairard B, Guidenfels C, Schaffer P, Mathelin C, Brettes JP. Le traitement hormonal substitutif de la ménopause: son impact sur la densité radiologique des seins et ses conséquences sur l'interprétation des mammographies. Gënësis 1998; 41: 15-9.
14. Chow C K, Venzon D, Jones E C, Premkumar A, O'Shaughnessy J Et Zujewski J.: Effect of Tamoxifen on Mammographic Density. Cancer Epidemiology Biomarkers & Prevention 2000; 9: 917-21.
15. Freedman M, San Martin J, O'Gorman J, Eckert S, Lippman M E, Lo SC, Walls EL, Zeng J.: Digitized mammography: a clinical trial of postmenopausal women randomly assigned to receive raloxifene, estrogen, or placebo. J Natl Cancer Inst 2001; 93: p 51-6.
16. McNicholas MMJ, Heneghan JP, Milner MH, Tunney T, Hourihane JB, Macerlaine DP.: Pain and increased mammographic density in women receiving hormone replacement therapy: a prospective study. Am J Roentgenol 1994; 163: 311-5.
17. Fitzgibbons PL, Henson DE, Hutter RV.: Benign breast changes and the risk for subsequent breast cancer - An update of the 1985 consensus statement. Cancer Committee of the College "of American Pathologists. Arch Pathol Lab Med 1998; 122: 1053-5.
18. Bird R, Wallace T, Yankaskas B.: Analysis of cancers missed at screening mammography. Radiology 1992; 184: 613-7.
19. Jackson VP, Hendrick RE, Feig SA, Kopans DB.: Imaging of the radiographically dense breast. Radiology 1993; 188: 297-301.
20. Rosenberg RD, Hunt WC, Williamson MR, Gilliland FD, Wiest PW, Kelsey CA, Key CR, Linver M.: Effects of age, breast density, ethnicity, and estrogen replacement therapy on screening mammographic sensitivity and cancer stage at diagnosis: review of 183,134 screening mammograms in Albuquerque, New-Mexico. Radiology 1998; 209: 511-8.
21. Sala E, Warren R, Mccann J, Duffy S, Day N, Luben R.: Mammographic parenchymal patterns and mode of detection: implications for the breast screening programme. J Med Screen 1998; 5: 207-12.
22. Mandelson MT, Oestreicher N, Porter PL, White D, Finder CA, Taplin SH, White E.: Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers. J Natl Cancer Inst 2000; 92: 1081-7.
23. Lehman CD, White E, Peacock S, Drucker MJ,.Urban N.: Effectof Age and Breast Density on Screening Mammograms with False-Positive Findings. Am J Roentgenol 1999; 173: 1651-5.
24. Meyer NE, Schaffer P, Hedelin G, Guldenfels C, Gairard B.: Impact du traitement hormonal substitutif de la ménopause sur la lecture des mammographies de dépistage. J Radiologie 2001; 82: 653-9.
25. Litherland JC, Evans AJ ET Wilson AR.: The effect of hormone replacement therapy on recall rate in the National Health Service Breast Screening Programme. Clin Radiol 1997; 52: 276-9.
26. Laya MB, Larson EB, Taplin SH, White E.: Effect of estrogen replacement therapy on the specificity and sensitivity of screening mammography. J Natl Cancer Inst 1996; 88: 643-9.
27. Byrne C.: Studying mammographic density: implications for understanding breast cancer (editorial, comment). J Nat Cancer Instit 1997; 89: 531-3.
28. Renaud R, Schaffer P, Gairard B, Dale G, Haenel P, Kleitz C, Guldenfels C.: Principe et premiers résultats de la Campagne Européenne de dépistage du cancer du sein dans le Bas-Rhin. Bull Acad Natl Med 1991; 175: 129-47.
29. Saftlas AF, Hoover RN, Brinton LA, Szklo M, Olson DR, Salane M, Wolfe JN.: Mammographic densities and risk of breast cancer. Cancer 1991; 67: 2833-8.
30. Warner E, Lockwood G, Tritchler D, Boyd NF.: The risk of breast cancer associated with mammographic parenchymal patterns: a meta-analysis of the published literature to examine the effect of method of classification. Cancer Detect Prev 1992; 16: 67-72.
31. Boyd NF, Byng JW, Jong RA, Fishell EK, Little LE, Miller AB, Lockwood GA, Tritchler DL, Yaffe MJ.: Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study. J Natl Cancer Inst 1995; 87: 670-5.
32. Salminen TM, Saarenmaa IE, Heikkila MM, Hakama M.: Is a dense mammographic parenchymal pattern a contraindication to hormonal replacement therapy? Acta Oncol 2000; 39: 969-72.
33. Byrne C, Schairer C, Brinton L A, Wolfe J, Parekh N, Salane M, Carter C, Hoover R.: Effects of mammographic density and benign breast disease on breast cancer risk (United States). Cancer Causes Control 2001: 12: 103-10.
34. Van Gils CH, Hendriks JH, Otten JD, Holland R, Verbeek AL.: Parity and mammographic breast density in relation to breast cancer risk: indication of interaction. Eur J Cancer Prev 2000; 9: 105-11.